{
    "Additional Indicators": [
        {
            "description": "Unfavorable Prognosis",
            "therapy": "NCCN, Consensus, Non-Small Cell Lung Cancer",
            "mutation": "KRASp.G12C Gain-of-function"
        }
    ],
    "Clinical trials": [
        {
            "description": "A Study of VS-6766 v. VS-6766 + Defactinib in Recurrent G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer ",
            "phase": "Phase 2",
            "mutations": [
                "KRAS"
            ]
        },
        {
            "description": "A Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1",
            "phase": "Phase 1/2",
            "mutations": [
                "KRAS",
                "STK11"
            ]
        },
        {
            "description": "First-in-human Study of DRP-104 (Sirpiglenastat) as Single Agent and in Combination With Atezolizumab in Patients With Advanced Solid Tumors. (NCT04471415)",
            "phase": "Phase 1/2",
            "mutations": [
                "NFE2L2",
                "STK11"
            ]
        }
    ],
    "variants of unknown significance": {
        "Somatic": [
            {
                "Gene": "CALR",
                "DNA Alteration": "c.1154_1155insTTGTC",
                "GeneMutation": "p.K385fs*47 Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "12.36%"
            },
            {
                "Gene": "GNAS",
                "DNA Alteration": "c.602G>A",
                "GeneMutation": "p.R160C Frameshift-GOF",
                "VariantAlleleFraction": "15.94%"
            },
            {
                "Gene": "SMO",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.A374E Spliceregionvariant-LOF",
                "VariantAlleleFraction": "5.84%"
            },
            {
                "Gene": "MAP2K2",
                "DNA Alteration": "c.383C>T",
                "GeneMutation": "p.P128L Frameshift-GOF",
                "VariantAlleleFraction": "5.07%"
            },
            {
                "Gene": "STAG2",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.R1012X Spliceregionvariant-LOF",
                "VariantAlleleFraction": "3.67%"
            },
            {
                "Gene": "PRKCA",
                "DNA Alteration": "c.1387G>C",
                "GeneMutation": "p.D463H Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "8.96%"
            },
            {
                "Gene": "KRAS",
                "DNA Alteration": "c.35_36delinsAA",
                "GeneMutation": "p.G12N Spliceregionvariant-LOF",
                "VariantAlleleFraction": "9.53%"
            },
            {
                "Gene": "CSF3R",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.G751A Frameshift-GOF",
                "VariantAlleleFraction": "5.99%"
            },
            {
                "Gene": "ARHGAP45",
                "DNA Alteration": "c.416G>A",
                "GeneMutation": "p.R139H Nonsense-GOF",
                "VariantAlleleFraction": "7.51%"
            },
            {
                "Gene": "NCSTN",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.A572G Frameshift-LOF",
                "VariantAlleleFraction": "3.44%"
            },
            {
                "Gene": "KLF1",
                "DNA Alteration": "c.115A>C",
                "GeneMutation": "p.A298P Frameshift-GOF",
                "VariantAlleleFraction": "1.92%"
            },
            {
                "Gene": "DNMT3A",
                "DNA Alteration": "c.2711C>T",
                "GeneMutation": "p.P904L Spliceregionvariant-LOF",
                "VariantAlleleFraction": "1.1%"
            }
        ],
        "Germline": []
    }
}